Moscow, Russia

Yury Ivanovich Kozlov

USPTO Granted Patents = 22 


 

Average Co-Inventor Count = 7.1

ph-index = 7

Forward Citations = 246(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can write an article about inventor Yury Ivanovich Kozlov for you.

Title: The Inventive Mind of Yury Ivanovich Kozlov

Introduction:

Yury Ivanovich Kozlov, a dedicated inventor based in Moscow, Russia, has made significant contributions to the field of biotechnology with a remarkable total of 22 patents to his name.

Latest Patents:

Kozlov's recent patents showcase his innovative prowess in the realm of bioprocessing and genetic engineering. One of his latest inventions involves enhancing the productivity of purine nucleosides and purine nucleotides using specific bacterial strains. Additionally, he has disclosed a method for producing valuable metabolites from acetyl-coenzyme A by modifying bacterial enzymes.

Career Highlights:

Currently employed at Ajinomoto Co., Ltd., Kozlov continues to push the boundaries of biological research and innovation. His expertise in genetic modification and metabolic engineering has led to groundbreaking developments in the field of biotechnology.

Collaborations:

In his inventive journey, Kozlov has collaborated closely with notable coworkers such as Konstantin Vyacheslavovich Rybak and Ekaterina Aleksandrovna Slivinskaya. Together, they have propelled forward various projects aimed at harnessing the potential of bacterial systems for industrial applications.

Conclusion:

Yury Ivanovich Kozlov's inventive spirit and dedication to scientific advancement have solidified his reputation as a pioneering figure in the realm of biotechnology. His numerous patents and collaborative efforts underscore his commitment to driving innovation and shaping the future of bioprocessing technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…